GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $391K invested in Grace Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

79% less capital invested

Capital invested by funds: $1.88M → $391K (-$1.49M)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$45.3K
2
+$38K
3
+$27K
4
UBS Group
UBS Group
Switzerland
+$2.47K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.42K

Top Sellers

1
-$350K
2
-$128K
3
-$53K
4
MMPW
Mitchell McLeod Pugh & Williams
Alabama
-$25K
5
Millennium Management
Millennium Management
New York
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$87K
2
$73K
3
$54K
4
$38K
5
$36K
6
$29K
7
$27K
8
$25K
9
$10K
10
$9K
11
$2K
12
$1K
13
$449
14
$6
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–